Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 76 (7), 1724-32

Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures With Prognostic Capability

Affiliations

Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures With Prognostic Capability

Xiangchun Li et al. Cancer Res.

Abstract

Gastric cancer is not a single disease, and its subtype classification is still evolving. Next-generation sequencing studies have identified novel genetic drivers of gastric cancer, but their use as molecular classifiers or prognostic markers of disease outcome has yet to be established. In this study, we integrated somatic mutational profiles and clinicopathologic information from 544 gastric cancer patients from previous genomic studies to identify significantly mutated genes (SMG) with prognostic relevance. Gastric cancer patients were classified into regular (86.8%) and hypermutated (13.2%) subtypes based on mutation burden. Notably, TpCpW mutations occurred significantly more frequently in regular, but not hypermutated, gastric cancers, where they were associated with APOBEC expression. In the former group, six previously unreported (XIRP2, NBEA, COL14A1, CNBD1, ITGAV, and AKAP6) and 12 recurrent mutated genes exhibited high mutation prevalence (≥3.0%) and an unexpectedly higher incidence of nonsynonymous mutations. We also identified two molecular subtypes of regular-mutated gastric cancer that were associated with distinct prognostic outcomes, independently of disease staging, as confirmed in a distinct patient cohort by targeted capture sequencing. Finally, in diffuse-type gastric cancer, CDH1 mutation was found to be associated with shortened patient survival, independently of disease staging. Overall, our work identified previously unreported SMGs and a mutation signature predictive of patient survival in newly classified subtypes of gastric cancer, offering opportunities to stratify patients into optimal treatment plans based on molecular subtyping. Cancer Res; 76(7); 1724-32. ©2016 AACR.

Similar articles

  • Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
    Hansford S, Kaurah P, Li-Chang H, Woo M, Senz J, Pinheiro H, Schrader KA, Schaeffer DF, Shumansky K, Zogopoulos G, Santos TA, Claro I, Carvalho J, Nielsen C, Padilla S, Lum A, Talhouk A, Baker-Lange K, Richardson S, Lewis I, Lindor NM, Pennell E, MacMillan A, Fernandez B, Keller G, Lynch H, Shah SP, Guilford P, Gallinger S, Corso G, Roviello F, Caldas C, Oliveira C, Pharoah PD, Huntsman DG. Hansford S, et al. JAMA Oncol. 2015 Apr;1(1):23-32. doi: 10.1001/jamaoncol.2014.168. JAMA Oncol. 2015. PMID: 26182300 Clinical Trial.
  • Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS, Vogelaar IP, Manders P, van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems MG, Gómez García EB, Wagner A, Hes FJ, Arts N, Mensenkamp AR, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ. van der Post RS, et al. Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11. Gastroenterology. 2015. PMID: 26072394
  • Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
    Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Gilpin C, Nikkel S, Connolly-Wilson M, Weissman S, Rubinstein WS, Sebold C, Greenstein R, Stroop J, Yim D, Panzini B, McKinnon W, Greenblatt M, Wirtzfeld D, Fontaine D, Coit D, Yoon S, Chung D, Lauwers G, Pizzuti A, Vaccaro C, Redal MA, Oliveira C, Tischkowitz M, Olschwang S, Gallinger S, Lynch H, Green J, Ford J, Pharoah P, Fernandez B, Huntsman D. Kaurah P, et al. JAMA. 2007 Jun 6;297(21):2360-72. doi: 10.1001/jama.297.21.2360. Epub 2007 Jun 3. JAMA. 2007. PMID: 17545690
  • Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
    Lim B, Kim JH, Kim M, Kim SY. Lim B, et al. World J Gastroenterol. 2016 Jan 21;22(3):1190-201. doi: 10.3748/wjg.v22.i3.1190. World J Gastroenterol. 2016. PMID: 26811657 Free PMC article. Review.
  • Genomic alterations and molecular subtypes of gastric cancers in Asians.
    Ye XS, Yu C, Aggarwal A, Reinhard C. Ye XS, et al. Chin J Cancer. 2016 May 9;35:42. doi: 10.1186/s40880-016-0106-2. Chin J Cancer. 2016. PMID: 27160712 Free PMC article. Review.
See all similar articles

Cited by 33 articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback